#AACR20 roundup: Tecentriq/Xtandi combo fails to show OS benefit, halting Roche's PD-L1 push into prostate cancer
For the first time in its 100-year-plus history, the American Association for Cancer Research is hosting its annual meeting completely online. Here’s a glance …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.